No effect on the short-term of a decrease in blood viscosity on insulin resistance

Clinical Hemorheology and Microcirculation

Volumn 68, Issue 1, 2018, Pages 45-50

  Gnasso, Agostino ^a   Cacia, Michele ^a   Cortese, Claudio ^b   Succurro, Elena ^a   Andreozzi, Francesco ^a   Carallo, Claudio ^a   Irace, Concetta ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

blood viscosity; clamp; iHOMA2; Insulin resistance

Indexed keywords

INSULIN;

ADULT; ARTICLE; BLOOD DONOR; BLOOD VISCOSITY; BODY MASS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTINUOUS INFUSION; ERYTHROCYTE DEFORMABILITY; HEMATOCRIT; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; IMPEDANCE; INSULIN RESISTANCE; MALE; QUESTIONNAIRE; SHEAR RATE; VISCOMETRY; WAIST CIRCUMFERENCE; IMMUNOLOGY; MIDDLE AGED; NORMAL HUMAN; PHYSIOLOGY;

ADULT; BLOOD VISCOSITY; HEALTHY VOLUNTEERS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED;

EID: 85045213259     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-170288     Document Type: Article

References (26)

1. Meiselman HJ, Merrill EW, Gilliland ER, Pelletier GA, Salzman EW. Influence of plasma osmolarity on the rheology of human blood. J Appl Physiol. 1967;22:772-81.
2. Lowe GD, Lowe JM, Drummond MM, et al. Blood viscosity in young male diabetics with and without retinopathy. Diabetologia. 1980;18:359-63.
3. Watala C, Zawodniak M, Bryszewska M, Nowak S. Non enzymatic protein glycosylation. I. Lowered erythrocyte membrane fluidity in juvenile diabetes. Ann Clin Res. 1985;17(6):327-30.
4. Cho YI, MooneyMP, Cho DJ. Hemorheological disorders in diabetes mellitus. J Diabetes SciTechnol. 2008;2(6):1130-8.
5. Guyton A, Hall J. Textbook of Medical Physiology. 10th ed. Philadelphia, PA, WB Saunders Company, 2000, pp. 212-3.
6. Salazar Vázquez BY, Martini J, Chávez Negrete A, Tsai AG, Forconi S, Cabrales P, Johnson PC, Intaglietta M. Cardiovascular benefits in moderate increases of blood and plasma viscosity surpass those associated with lowering viscosity: Experimental and clinical evidence. Clin Hemorheol Microcirc. 2010;44(2):75-85. doi: 10. 3233/CH-2010-1261
7. Tamariz LJ, Young JH, Pankow JS, Yeh HC, Schmidt MI, Astor B, Brancati FL. Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: The atherosclerosis risk in communities (ARIC) study Am J Epidemiol. 2008;168:1153-60.
8. Brun JF, Monnier JF, Pérez-Martin A, Andrieu JM, Orsetti A. Blood viscosity is negatively correlated to insulin sensitivity. Haemostasis. 1996;26:S3 (abstract 597).
9. Høieggen A, Fossum E, Moan A, Enger E, Kjeldsen SE. Whole-blood viscosity and the insulin-resistance syndrome. J Hypertens. 1998;16(2):203-10.
10. Capo?glu I, Unuvar N, Bektaş Y, Yilmaz O, Kaya MD. The effects of high haematocrit levels on glucose metabolism disorders. J Int Med Res. 2002;30:433-7.
11. Wannamethee SG, Perry IJ, Shaper AG. Hematocrit and risk of NIDDM. Diabetes. 1996;45:576-9.
12. Tulloch-Reid MK, Hanson RL, Saremi A, Looker HC, Williams DE, Krakoff J, Knowler WC. Hematocrit and the incidence of type 2 diabetes in the pima indians. Diabetes Care. 2004;27:2245-46.
13. Irace C, Carallo C, Scavelli F, De Franceschi MS, Esposito T, Gnasso A. Blood viscosity in subjects with normoglycemia and prediabetes. Diabetes Care. 2014;37(2):488-92.
14. Marini MA, Fiorentino TV, Andreozzi F, Mannino GC, Succurro E, Sciacqua A, Perticone F, Sesti G. Hemorheological alterations in adults with pre-diabetes identified by hemoglobin A1c levels. Nutr Metab Cardiovasc Dis. doi: http://dx. doi. org/10. 1016/j. numecd. 2017. 04. 001
15. Marini MA, Succurro E, Frontoni S, Mastroianni S, Arturi F, Sciacqua A, Lauro R, Hribal ML, Perticone F, Sesti G. Insulin sensitivity, -cell function, and incretin effect in individuals with elevated 1-h postload plasma glucose levels. Diabetes Care. 2012;35:868-72.
16. Diabetes Trials Unit, Oxford, UK. HOMA Calculator v2. 2. 3. http://www. dtu. ox. ac. uk (Accessed July 2017).
17. Hill NR, Levy JC, Matthews DR. Expansion of the homeostasis model assessment of -cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2. Diabetes Care. 2013;36(8):2324-30. doi: 10. 2337/dc12-0607. Epub. 2013 Apr 5.
18. McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA, Duncan AW. Diagnosing insulin resistance in the general population Diabetes Care. 2001;24(3):460-4.
19. Devereux RB, Case DB, Alderman MH, Pickering TG, Chien S, Laragh JH. Possible role of increased blood viscosity in the hemodynamics of systemic hypertension Am J Cardiol. 2000;85:1265-8.
20. Cowan AQ, Cho DJ, Rosenson RS. Importance of blood rheology in the pathophysiology of atherothrombosis. Cardiovasc Drugs Ther 2012;26(4):339-48. doi: 10. 1007/s10557-012-6402-4
21. Zöllei E, Paprika D, Makra P, Gingl Z, Vezendi K, Rudas L. Human autonomic responses to blood donation. Auton Neurosci. 2004;110(2):114-20.
22. TamCS, XieW, Johnson WD, CefaluWT, Redman LM, Ravussin E. Defining insulin resistance from hyperinsulinemiceuglycemic clamps. Diabetes Care 2012;35(7):1605-10. doi: 10. 2337/dc11-2339. Epub. 2012 Apr 17
23. Moan A, Høieggen A, Nordby G, Birkeland K, Eide I, Kjeldsen SE. The glucose clamp procedure activates the sympathetic nervous system even in the absence of hyperinsulinemia. J Clin Endocrinol Metab. 1995;80(11):3151-4.
24. McMillan DE. Disturbance of serum viscosity in diabetes mellitus. J Clin Invest. 1974;53(4):1071-9.
25. Skovborg F, Nielsen AV, Schlichtkrull J, Ditzel J. Blood-viscosity in diabetic patients. Lancet. 1966;1:129-31.
26. Bonnin P, Vilar J, Levy BI. Effect of normovolemic hematocrit changes on blood pressure and flow. Life Sci. 2016;157:62-6.